Tamsalani, Amrulkhais A.
HRN: 21-57-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2022
AMPICILLIN 250MG (VIAL)
08/05/2022
08/12/2022
IVT
60mg
Q12
Perinatal Asphyxia
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes